Rockwell Medical, Inc. held its 2026 Annual Meeting of Stockholders on June 12, 2026. Shareholders approved the election of Class II directors Joseph Dawson and Joan Lau, Ph.D., and ratified EisnerAmper LLP as the independent auditor for 2026. However, stockholders rejected the advisory vote on executive compensation and failed to approve an amendment to the Certificate of Incorporation to effect a reverse stock split. Rockwell Medical, Inc. is a medical technology company.
